The Journal of Experimental Medicine
Avanti Polar Lipids, Inc.
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online
doi:10.1084/jem.20072327
The Journal of Experimental Medicine, Vol. 205, No. 10, 2419-2435
The Rockefeller University Press, 0022-1007 $30.00
© Guo et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 2417K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guo, H.
Right arrow Articles by Malarkannan, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guo, H.
Right arrow Articles by Malarkannan, S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

The p110{delta} of PI3K plays a critical role in NK cell terminal maturation and cytokine/chemokine generation

Hailong Guo1, Asanga Samarakoon1, Bart Vanhaesebroeck3, and Subramaniam Malarkannan1,2

1 Laboratory of Molecular Immunology, Blood Research Institute and 2 Department of Medicine, Medical College of Wisconsin, Milwaukee, WI 53226
3 Centre for Cell Signaling, Institute of Cancer, Queen Mary, University of London, Charterhouse Square, London EC1M 6BQ, England, UK

CORRESPONDENCE Subramaniam Malarkannan: subra.malar{at}bcw.edu

Phosphatidylinositol 3-kinases (PI3Ks) play a critical role in regulating B cell receptor– and T cell receptor–mediated signaling. However, their role in natural killer (NK) cell development and functions is not well understood. Using mice expressing p110{delta}D910A, a catalytically inactive p110{delta}, we show that these mice had reduced NK cellularity, defective Ly49C and Ly49I NK subset maturation, and decreased CD27High NK numbers. p110{delta} inactivation marginally impaired NK-mediated cytotoxicity against tumor cells in vitro and in vivo. However, NKG2D, Ly49D, and NK1.1 receptor–mediated cytokine and chemokine generation by NK cells was severely affected in these mice. Further, p110{delta}D910A/D910A NK cell–mediated antiviral responses through natural cytotoxicity receptor 1 were reduced. Analysis of signaling events demonstrates that p110{delta}D910A/D910A NK cells had a reduced c-Jun N-terminal kinase 1/2 phosphorylation in response to NKG2D-mediated activation. These results reveal a previously unrecognized role of PI3K-p110{delta} in NK cell development and effector functions.


Abbreviations used: 7-AAD, 7-aminoactinomycin D; CHO, Chinese hamster ovary; ERK, extracellular signal-regulated kinase; HA, hemagglutinin; ITAM, immunoreceptor tyrosine-based activation motif; JNK, c-Jun N-terminal kinase; MAPK, mitogen-activated protein kinase; MIP, macrophage inflammatory protein; MOI, multiplicity of infection; NCR, natural cytotoxicity receptor; NKP, NK precursor; PI3K, phosphatidylinositol 3-kinase; PTK, protein tyrosine kinase; RANTES, regulated upon activation, normal T cell expressed and secreted; YINM, Tyr-Ile-Asn-Met.

© 2008 Guo et al. This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jem.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS